Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Aviat Networks
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Pasolink Acquisition, MB Max Product, And Thailand Expansion Will Boost Future Earnings
Key Takeaways Pasolink acquisition and MB Max product boost growth prospects and margins through higher capacity and cost efficiency. Expanding Thai manufacturing and a focus on cybersecurity could improve gross margins and attract more customers in utilities and private networks.
View narrative
US$35.17
FV
34.1% undervalued
intrinsic discount
5.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
2 days ago
author updated this narrative
Eli Lilly
AN
AnalystHighTarget
Consensus Narrative from 27 Analysts
Aging And Obesity Trends Will Expand Global Chronic Markets
Key Takeaways Small molecule innovation, manufacturing scale, and direct-to-consumer models position Eli Lilly for market dominance, outperformance, and premium pricing resilience. Demographic trends, new technologies, and ongoing R&D investments are set to drive sustained volume growth, innovation, and long-term earnings expansion.
View narrative
US$1.16k
FV
38.9% undervalued
intrinsic discount
23.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
2 days ago
author updated this narrative
Lovesac
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
EverCouch And Reclining Seat Will Drive Market Expansion
Key Takeaways Continued innovation and new product launches are expected to expand the market and drive revenue growth. Strong supply chain management and tailored customer acquisition strategies are likely to improve margins and boost revenue growth.
View narrative
US$30.17
FV
36.7% undervalued
intrinsic discount
9.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
2 days ago
author updated this narrative
ReposiTrak
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Regulatory Changes Will Drive Future Demand For Grocery Traceability Solutions
Key Takeaways Strategic focus on automation and partnerships enhances scalability, market reach, and incremental profitability, improving margins by reducing costs. Anticipated double-digit growth, driven by traceability demand and strategic initiatives, signals substantial earnings improvement and increased shareholder value.
View narrative
US$29.00
FV
41.9% undervalued
intrinsic discount
11.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Designer Brands
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Revamped Leadership And Brand Focus Will Expand Market Reach
Key Takeaways Revamped leadership and strategies aim to enhance operational efficiencies, driving earnings growth through an optimized brand portfolio and private label expansion. Strategic investments and expanded omnichannel reach are expected to boost revenue, margins, and overall profitability through market reach and sales growth.
View narrative
US$3.50
FV
2.3% overvalued
intrinsic discount
0.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
DocGo
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
At-home Healthcare Expansion Will Capture Growing Demand
Key Takeaways Expansion into proactive, home-based healthcare and strong ties with major payers support long-term revenue growth and stability. Technology adoption and logistics investments drive efficiency, margin improvement, and scalable entry into new markets and services.
View narrative
US$3.05
FV
43.6% undervalued
intrinsic discount
-12.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 days ago
author updated this narrative
First Bank
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Platform Investments And Branch Expansion Will Unlock New Markets
Key Takeaways Strong loan and deposit growth, digital investment, and geographic expansion position First Bank for sustainable revenue and customer base gains. Enhanced risk management, expense control, and lower funding costs support consistent profitability and long-term margin improvement.
View narrative
US$18.67
FV
11.0% undervalued
intrinsic discount
10.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Lincoln Educational Services
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
New Campuses And Flexible Learning Will Boost Technical Training Enrollment
Key Takeaways Enrollment and revenue growth are fueled by strong demand for skilled trades, innovative learning models, and expansion in underserved metro areas. Robust employer partnerships and high school initiatives enhance student acquisition, tuition pricing power, and long-term earnings visibility.
View narrative
US$26.20
FV
23.2% undervalued
intrinsic discount
9.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 days ago
author updated this narrative
Voyager Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Tau-Targeting Therapies May Transform Alzheimer's Treatment Despite Clinical Uncertainties
Key Takeaways Voyager Therapeutics' innovative focus on tau-targeting programs in Alzheimer's could capture significant market demand, boosting future earnings and revenue. Strategic partnerships and promising technological advancements ensure non-dilutive revenue growth and potential stock revaluation, enhancing long-term net margins and earnings per share.
View narrative
US$15.67
FV
78.1% undervalued
intrinsic discount
29.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies